Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?

Cristina Gervasoni(University of Padua), Dario Cattaneo(ASST Fatebenefratelli Sacco), Emilio Clementi(Luigi Sacco Hospital), Giuliano Rizzardini, Davide Minisci(University of Brescia), Simona Landonio(ASST Fatebenefratelli Sacco), Lara Molinari(Luigi Sacco Hospital), Laurenzia Ferraris(Luigi Sacco Hospital), Agostino Riva(ASST Fatebenefratelli Sacco), Valeria Cozzi(Luigi Sacco Hospital), Paola Meraviglia(Luigi Sacco Hospital), Nitin B. Charbe, Massimo Galli(Luigi Sacco Hospital)
PLoS ONE
April 15, 2015
Cited by 28


Related Papers